STRATUMfiling intelligence๐Ÿ‡ฎ๐Ÿ‡ณ Indian private portal

CIK 1641640

Nabriva Therapeutics plc
CIK 0001641640 ยท EDGAR โ†—
cleanelevatedtriggeredno dataplanned
80.4
composite ยท 3 signals ยท TRIGGERED

Every card below shows the score and the exact filing data it was computed from โ€” no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded โ€” never a guess.

Chat with this filing โ†’

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo โ€” generate one โ†’

Run the bounded investigation agent โ€” reads this company's signals and writes a short, cited summary.

Signals

P-13 ยท FY 2022-12-31 ยท TRIGGERED100.0

Zombie / distress

Zombie: interest coverage below 1.0x for 4 consecutive years
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2023-04-17) โ†—
Evidence โ€” inputs and thresholds
{
  "icr_by_year": {
    "2022-12-31": -79.499,
    "2021-12-31": -53.86,
    "2020-12-31": -40.101,
    "2019-12-31": -23.455
  },
  "consecutive_years_below_1": 4,
  "altman_z_double_prime": -77.897,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -55490000,
    "interest_expense_t": 698000
  },
  "stale": false,
  "latest_filing_period": "2022-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1641640/000155837023006062/0001558370-23-006062-index.htm",
    "form": "10-K",
    "filed": "2023-04-17"
  }
}
P-12 ยท FY 2022-12-31 ยท ELEVATED53.2

Restatement predictor

F-Score 1.60 โ€” misstatement risk 1.6x the base rate
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2023-04-17) โ†—
Evidence โ€” inputs and thresholds
{
  "f_score": 1.597,
  "probability": 0.00591,
  "components": {
    "rsst": -0.3634,
    "drec": -0.0989,
    "dinv": -0.0858,
    "soft": 0.6004,
    "dcs": 0.471,
    "droa": -1.1891,
    "issue": 1
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2022-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1641640/000155837023006062/0001558370-23-006062-index.htm",
    "form": "10-K",
    "filed": "2023-04-17"
  }
}
P-01 ยท FY 2022-12-31 ยท CLEAN0.0

Earnings quality

Beneish M-Score -5.06 โ€” no manipulation profile
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2023-04-17) โ†—
Evidence โ€” inputs and thresholds
{
  "m_score": -5.062,
  "threshold": -1.78,
  "ratios": {
    "DSRI": 0.286,
    "GMI": 2.409,
    "AQI": 2.361,
    "SGI": 1.278,
    "DEPI": 1.384,
    "SGAI": 0.686,
    "LVGI": 2.68,
    "TATA": -0.645
  },
  "defaulted_to_neutral": [],
  "sloan_accruals": -0.3634,
  "inputs": {
    "revenue_t": 36935000,
    "revenue_t1": 28895000,
    "total_assets_t": 31765000,
    "net_income_t": -57185000,
    "cfo_t": -36711000
  },
  "stale": false,
  "latest_filing_period": "2022-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1641640/000155837023006062/0001558370-23-006062-index.htm",
    "form": "10-K",
    "filed": "2023-04-17"
  }
}